IL-6R distribution in normal human and cynomolgus monkey tissues

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Interleukin-6 (IL-6) is a key cytokine implicated in various diseases, including rheumatoid arthritis and multiple myeloma.
• Blocking the IL-6/interleukin-6 receptor (IL-6R)/gp130 pathway is a therapeutic strategy.
• Tocilizumab is a humanized antibody targeting IL-6R.

Purpose of the Study:

• To determine the distribution of IL-6R in normal human and cynomolgus monkey tissues.
• To provide foundational data for preclinical and clinical studies of tocilizumab.
• To compare IL-6R expression patterns between humans and cynomolgus monkeys.

Main Methods:

• Tissue sections from human and cynomolgus monkeys were stained using an Envision immunoperoxidase method.
• Commercially available anti-human IL-6R antibody was used for staining.
• Species- and isotype-matched negative control antibodies and assay control slides were employed.

Main Results:

• IL-6R expression was detected across multiple systems in both human and cynomolgus monkey tissues.
• Positive reactions were observed in lymphatic, hematopoietic, digestive, reproductive, endocrine, neural, muscular, epidermal, respiratory, and urinary systems.
• IL-6R distribution patterns were found to be similar in both species.

Conclusions:

• The study successfully mapped IL-6R distribution in human and cynomolgus monkey tissues.
• The observed similarity in IL-6R expression supports the use of cynomolgus monkeys as a model for preclinical studies.
• This data is crucial for the interpretation of tocilizumab's efficacy and safety in clinical trials.